NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials; Board on Health Care Services; Board on Health Sciences Policy; Institute of Medicine; Micheel CM, Nass SJ, Omenn GS, editors. Evolution of Translational Omics: Lessons Learned and the Path Forward. Washington (DC): National Academies Press (US); 2012 Mar 23.
Evolution of Translational Omics: Lessons Learned and the Path Forward.
Show details- GILBERT S. OMENN (Chair), Professor of Internal Medicine, Human Genetics and Public Health; Director, University of Michigan Center for Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor
- CATHERINE D. DEANGELIS, Professor of Pediatrics, Johns Hopkins School of Medicine, Professor of Health Policy and Management, Johns Hopkins School of Public Health, and Editor-in-Chief Emerita, Journal of the American Medical Association, Baltimore, MD
- DAVID L. DEMETS, Professor of Statistics and Biostatistics, University of Wisconsin, Madison
- THOMAS R. FLEMING, Professor of Biostatistics, Statistics, University of Washington, Seattle
- GAIL GELLER, Professor of Medicine, Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD
- JOE GRAY, Gordon Moore Endowed Chair, Department of Biomedical Engineering, Center for Spatial Systems Biomedicine, Oregon Health & Science University Knight Cancer Institute, Portland
- DANIEL F. HAYES, Clinical Director of the Breast Oncology Program, and Stuart B. Padnos Professor of Breast Cancer Research, University of Michigan Comprehensive Cancer Center, Ann Arbor
- I. CRAIG HENDERSON, Adjunct Professor of Medicine, University of California, San Francisco and Helen Diller Family Comprehensive Cancer Center
- LARRY KESSLER, Professor and Chair, Department of Health Services, University of Washington School of Public Health, Seattle
- STANLEY LAPIDUS, Founder, President, and CEO, SynapDx Corporation, Southborough, MA
- DEBRA G. B. LEONARD, Professor and Vice Chair for Laboratory Medicine, and Director of the Clinical Laboratories, Weill Medical College of Cornell University, New York, NY
- HAROLD L. MOSES, Director Emeritus, Hortense B. Ingram Professor of Molecular Oncology, and Professor of Cancer Biology, Medicine, and Pathology, Vanderbilt-Ingram Cancer Center, Nashville, TN
- WILLIAM PAO, Associate Professor of Medicine, Cancer Biology, and Pathology, Microbiology, Immunology, Ingram Associate Professor of Cancer Research, Director of the Division of Hematology/Oncology, and Director of Personalized Cancer Medicine, Vanderbilt University School of Medicine, Nashville, TN
- REBECCA D. PENTZ, Professor of Hematology and Oncology in Research Ethics, Emory School of Medicine, Atlanta, GA
- NATHAN D. PRICE, Associate Professor, Institute for Systems Biology, Seattle, WA
- JOHN QUACKENBUSH, Professor of Computational Biology and Bioinformatics, Dana-Farber Cancer Institute, Boston, MA
- ELDA RAILEY, Cofounder, Research Advocacy Network, Plano, TX
- DAVID RANSOHOFF, Professor of Medicine, Clinical Professor of Epidemiology, University of North Carolina, School of Medicine and Gillings School of Global Public Health, Chapel Hill
- E. ALBERT REECE, Vice President for Medical Affairs, University of Maryland, and John Z. and Akiko K. Bowers Distinguished Professor and Dean, University of Maryland School of Medicine, Baltimore
- DANIELA M. WITTEN, Assistant Professor of Biostatistics, University of Washington, Seattle
IOM Staff
- CHRISTINE M. MICHEEL, Study Director (through November 2011)
- SHARYL J. NASS, Director, National Cancer Policy Forum; Study Director (from December 2011)
- LAURA LEVIT, Program Officer (from June 2011)
- ERIN BALOGH, Associate Program Officer
- SARAH DOMNITZ, Christine Mirzayan Science and Technology Policy Graduate Fellow (from August to December 2011)
- JULIA E. DOOHER, Christine Mirzayan Science and Technology Policy Graduate Fellow (from January to May 2011)
- NIHARIKA SATHE, Research Assistant (from June 2011)
- MICHAEL PARK, Senior Program Assistant
- PATRICK BURKE, Financial Associate
- ROGER HERDMAN, Director, Board on Health Care Services
- ANDREW POPE, Director, Board on Health Sciences Policy
Consultant
- JOHN BAILAR, Scholar in Residence
- COMMITTEE ON THE REVIEW OF OMICS-BASED TESTS FOR PREDICTING PATIENT OUTCOMES IN ...COMMITTEE ON THE REVIEW OF OMICS-BASED TESTS FOR PREDICTING PATIENT OUTCOMES IN CLINICAL TRIALS - Evolution of Translational Omics
- AGL [Chlamydotis macqueenii]AGL [Chlamydotis macqueenii]Gene ID:104482712Gene
- LOC107692482 [Sinocyclocheilus anshuiensis]LOC107692482 [Sinocyclocheilus anshuiensis]Gene ID:107692482Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...